Status:

UNKNOWN

Mini-invasive Preventive Fixation of the Contralateral Femoral Neck in Patients Operated on for a Femoral Neck Fracture

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Conditions:

Femoral Neck Fractures

Eligibility:

All Genders

80+ years

Phase:

PHASE3

Brief Summary

In France, the annual incidence of hip fracture is about 80 000 with more than 75% of these fractures occurring in patients aged 80 years old or more. About 10% percent of patients presenting with a h...

Eligibility Criteria

Inclusion

  • women and men
  • 80 years or older
  • operated on for a femoral neck fracture
  • presenting one, or more, added clinical risk factor of hip fracture\*
  • a fragility fracture in the past five years
  • a history of fall in the past 12 months (not considering the fall that led to the present fracture)
  • a very high risk of falling: use of psychoactive medication or impaired vision or impaired neuromuscular function
  • BMI lower than 20kg/m2
  • giving her/his consent.
  • affiliated to the social security

Exclusion

  • history of a contralateral proximal femoral fracture
  • history of a surgical operation of the contralateral proximal femur
  • ongoing infection (bone or soft-tissue) on the contralateral hip
  • contraindication of MIPF of the contralateral hip
  • non ambulatory patients
  • patients already included in the study
  • patients with contraindication to the medical devices under evaluation
  • patients not suitable for a surgical procedure (including not suitable for an anaesthetic)
  • patients with a benign or malignant bone lesion of the contralateral femur
  • patients included in another clinical research which could directly have an effect on the femoral neck bone strength
  • patients presenting with a grade 4 Kellgren-Lawrence osteoarthritis of the contralateral hip and reporting significant clinical symptoms
  • patients with an life expectancy of less than 3 months
  • patients with a legal representative (tutorship or guardianship) and insane patients will be excluded

Key Trial Info

Start Date :

September 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2025

Estimated Enrollment :

812 Patients enrolled

Trial Details

Trial ID

NCT04408053

Start Date

September 1 2020

End Date

September 1 2025

Last Update

May 29 2020

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.